F

Fletcher Spaght, Inc.

29 employees

Fletcher Spaght, Inc. provides strategy and financial assistance to new ventures including start-ups.

Investor insights

Countries invested in

united states1

Sectors invested in

Biotechnology17
Health Care12
Medical12
Medical Device11
Health Diagnostics7
Pharmaceutical5
slow absorption5
Ticagrelor reversal agent5
Pulmonary Arterial Hypertension5
cardiopulmonary disorders5
DMD cardiomyopathy5
improved biotherapeutics5
Orphan diseases5
Elastin-like polypeptide biopolymer5
phase transition5
Heart failure5
Vasoactive Intestinal Peptide5
Software3
Life Science3
precision medicine3

Funding rounds participated in

$11M sweet spot round size

Most of their 27 investments are in rounds between $6.6M and $16M

Investor type

Micro VC

Basic info

Industry

business consulting and services

Sectors

Medical Device
therapeutics
information technology
healthcare IT
technology-enabled businesses
high technology
diagnostics
digital health
healthcare services
strategy consulting
Consumer
medical devices
Consulting
Medical
life sciences
Information Technology
biotech

Date founded

1983

Investments made

P

PhaseBio Pharmaceuticals, Inc. raised $34M on September 5, 2018

Investors: Syno Capital, Mountain Group Partners and Fletcher Spaght, Inc.

H

HistoSonics, Inc. raised $8.3M on March 13, 2017

Investors: Grand Angels, TGap Ventures, EARLY STAGE PARTNERS L.P., Wolverine Venture Fund, Venture Investors and Fletcher Spaght, Inc.

S

Swift Biosciences, Inc raised $3M on April 15, 2016

Investors: Michigan Accelerator Fund I, Draper Associates and Fletcher Spaght, Inc.

P

PhaseBio Pharmaceuticals, Inc. raised $40M on March 12, 2015

Investors: Fletcher Spaght, Inc.

M

Metabolon, Inc. raised $15M on January 6, 2014

Investors: Fulcrum Equity Partners, Sumitomo Corporation, Camden Partners and Fletcher Spaght, Inc.

S

Swift Biosciences, Inc raised $7M on October 17, 2013

Investors: Renaissance Venture Capital Fund and Fletcher Spaght, Inc.

S

SURGIQUEST raised $7.5M on December 5, 2012

Investors: Presidio Partners, Aphelion Capital, California Technology Ventures, LLC, River Cities Capital and Fletcher Spaght, Inc.

J

Juventas Therapeutics, Inc. raised $22M on July 16, 2012

Investors: EARLY STAGE PARTNERS L.P., -, Takeda UK Limited, Triathlon Medical Ventures, Venture Investors and Fletcher Spaght, Inc.

P

PhaseBio Pharmaceuticals, Inc. raised $23M on June 5, 2012

Investors: Astellas Venture Capital L.L.C. and Fletcher Spaght, Inc.

C

Cayenne Medical raised $10M on February 14, 2012

Investors: MB Venture Partners, LLC, Capital Growth Investments Inc, Split Rock Partners and Fletcher Spaght, Inc.

FAQ